In vitro and in vivo Drug Studies with Three Agents of Central Nervous System Phaeohyphomycosis
- 1 January 1987
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 33 (2) , 129-140
- https://doi.org/10.1159/000238485
Abstract
Amphotericin B (Amph B), 5-fluorocytosine (5-FC), ketoconazole (KTZ), fluconazole (FLZ), amorolfine (AMOR) and terbinafine (TER) were tested against 3 agents of central nervous system phaeohyphomycosis in vitro and in life-threatening infections in mice. The fungi studied were Cladosporium bantianum, Dactylaria constricta and Wangiella dermatitidis. The broadest protection against this group of fungi in mice was offered by 5-FC followed by Amph and FLZ, then KTZ. AMOR and TER were inactive in vivo. The results of in vitro susceptibility testing had no predictive value. In contrast, the data obtained from the mouse models should be useful clinically.This publication has 12 references indexed in Scilit:
- Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858)Medical Mycology, 1986
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- In vitro studies with R 51,211 (itraconazole)Antimicrobial Agents and Chemotherapy, 1984
- Critical Review of Human Isolates of Wangiella dermatitidisMycologia, 1984
- INVITRO STUDIES WITH 4 NEW ANTIFUNGAL AGENTS - BAY N 7133, BIFONAZOLE (BAY H-4502), ICI 153,066 AND RO 14-4767/0021984
- Antimycotic therapy of experimental infections caused by dematiaceous fungiMedical Mycology, 1984
- Susceptibility of dematiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combinationMedical Mycology, 1982
- A COMPARISON OF BIFONAZOLE (BAY-H-4502) WITH CLOTRIMAZOLE INVITRO1982
- Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in MiceChemotherapy, 1982
- Comparison of the in Vitro Antifungal Activities of Miconazole and a New Imidazole, R41,400The Journal of Infectious Diseases, 1978